Sep. 3 at 5:30 PM
$SLS $JNJ Mr. Cavanaugh took over Johnson & Johnson's : Executive Vice President Jennifer Taubert to Retire;
Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September.
Ms. Kalin worked with Mr. Cavanaugh for 10 plus years and were principal facilitators of
$74 Billion Celgene deal.
$JNJ Executives have openly praised
$SLS GPS and I consider them # 1 suitor on the table right now.
✌️🙏❤️🩹